First Adult Injection of Dotarem® (gadoterate meglumine) in US
Guerbet LLC, USA (September 05, 2013)
Princeton, NJ -- Guerbet announced today that Winthrop-University Hospital in Mineola, NY, recently performed the first US adult injection of Dotarem® (gadoterate meglumine), the only macrocyclic and ionic gadolinium-based contrast agent (GBCA) approved by the US Food and Drug Administration. The procedure was performed in an adult with borderline renal function. It follows the first pediatric injection of Dotarem at Cincinnati Children’s Hospital Medical Center.